Alain Mita, MD

Co-Director, Experimental Therapeutics Program

Alain Catalin Mita, MD, is co-director of the Experimental Therapeutics Program at the Samuel Oschin Comprehensive Cancer Institute. He is also a member of the multidisciplinary thoracic and head and neck clinics at the cancer institute.

Dr. Mita's research focuses on the development of early clinical trials of novel therapeutic agents. His clinical focus is in medical oncology and experimental cancer therapies. He served as a principal investigator for more than 40 Phase I clinical trials, including several first-in-human trials.

Dr. Mita has authored more than 60 articles appearing in peer-reviewed publications and is a peer reviewer for many of those journals. He has presented more than 100 abstracts and has lectured at numerous conferences and meetings.

In addition to being a member of the American Society for Clinical Oncology, Dr. Mita is a member of the European Society for Medical Oncology, the American Association for Cancer Research and the Southwest Oncology Group (Thoracic and Early Therapeutics committees). He has earned grants and awards, including a research grant from the Association for Research Against Cancer, a merit award from the American Society of Clinical Oncology and a scholar-in-training award from the American Association for Cancer Research.

After earning his medical degree at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, Dr. Mita earned a specialty diploma in medical oncology at Paul Sabatier University in Toulouse, France, and completed specialty training in cancer research at Paul Brousse Hospital in Villejuif, France. He received additional specialty training in oncology at Paul Brousse Hospital, Rene Huguenin Center, Caludius Regaud Center, Purpan Hospital and Municipal Hospital, all in France. He completed an advanced fellowship in Drug Development at the Cancer Therapy and Research Center of the University of Texas Health Science Center at San Antonio, where he served as a staff physician from 2006 to 2011.